"Submit your manuscript to the Journal of Neurology and Neurological Sciences and share your research with the global neurology community."
Submit Manuscript Contact Us
The Journal of Neurology and Neurological Sciences is a leading peer-reviewed and open-access publication dedicated to the advancement of knowledge in the field of neurology. It serves as a platform for sharing research on the nervous system, focusing on a wide array of topics that span both clinical and experimental neurology. By maintaining rigorous academic standards, the journal ensures that each article published contributes meaningfully to the global understanding of neurological disorders and treatments.
Read MoreThe number of people developing dementia is expected to rapidly increase given the aging population. Effective treatments are lacking necessitating the development of intervention strategies to target modifiable risk factors.
To investigate the association between light-to-moderate alcohol consumption, serum cholesterol levels, and dementia incidence among community-dwelling older adults in Tianjin. A cross-sectional study of 3536 community-dwelling elderly (aged ≥65 years) in Tianjin from April to June 2019. Dementia was diagnosed using the International Classification of Diseases.
Olfactory dysfunction is one of the leading prodromal symptoms of Parkinson´s Disease (PD) [1], and has been investigated extensively in the past. However, hyposmia is generally considered a binary trait in manifest PD and less attention has been paid to the quantitative evolution of hyposmia after the clinical diagnosis of PD.
This paper is a review paper examining relationships between the brain and crime. Based on a literature review from searches of two academic databases—ProQuest and Academic Search Complete—the paper summarizes what has been demonstrated about the brain and crime from the most recent peer-reviewed journal articles on the subject matter.
The Relapsing-Remitting form of Multiple Sclerosis (RRMS) affects 85% of patients, characterized by alternating onset and remission of disease symptoms. The standard treatment for MS relapse is pulse corticosteroid therapy. In this study, the efficacy of a combination of neuropeptides (metenkephalin and tridecactid).